These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30032832)

  • 1. Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer.
    Izumi H; Yamasaki A; Takeda K; Kodani M; Touge H; Tanaka N; Yanai M; Ueda Y; Sakamoto T; Nishii-Ito S; Makino H; Yamaguchi K; Igishi T; Shimizu E
    Lung Cancer; 2018 Aug; 122():200-205. PubMed ID: 30032832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation: the case of zoledronic acid-induced acute phase reaction.
    De Santis M; Cavaciocchi F; Ceribelli A; Crotti C; Generali E; Fabbriciani G; Selmi C; Massarotti M
    Lupus; 2015 Apr; 24(4-5):442-7. PubMed ID: 25801887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
    Li Z; Tang J; Sun L; Ye Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.
    Rossini M; Adami S; Viapiana O; Ortolani R; Vella A; Fracassi E; Gatti D
    J Bone Miner Res; 2012 Jan; 27(1):227-30. PubMed ID: 21956654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
    Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
    Front Immunol; 2018; 9():753. PubMed ID: 29706966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate stimulates gamma delta T cells in prostate cancer patients.
    Naoe M; Ogawa Y; Takeshita K; Morita J; Shichijo T; Fuji K; Fukagai T; Iwamoto S; Terao S
    Oncol Res; 2010; 18(10):493-501. PubMed ID: 20681408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.
    Kobayashi H; Tanaka Y; Yagi J; Minato N; Tanabe K
    Cancer Immunol Immunother; 2011 Aug; 60(8):1075-84. PubMed ID: 21519826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.
    Dieli F; Vermijlen D; Fulfaro F; Caccamo N; Meraviglia S; Cicero G; Roberts A; Buccheri S; D'Asaro M; Gebbia N; Salerno A; Eberl M; Hayday AC
    Cancer Res; 2007 Aug; 67(15):7450-7. PubMed ID: 17671215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of amino-bisphosphonates on circulating γδ T cells.
    Rossini M; Adami S; Viapiana O; Fracassi E; Ortolani R; Vella A; Zanotti R; Tripi G; Idolazzi L; Gatti D
    Calcif Tissue Int; 2012 Dec; 91(6):395-9. PubMed ID: 23052225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronate promotes inflammatory cytokine expression in human CD14-positive monocytes among peripheral mononuclear cells in the presence of γδ T cells.
    Takimoto R; Suzawa T; Yamada A; Sasa K; Miyamoto Y; Yoshimura K; Sasama Y; Tanaka M; Kinoshita M; Ikezaki K; Ichikawa M; Yamamoto M; Shirota T; Kamijo R
    Immunology; 2021 Mar; 162(3):306-313. PubMed ID: 33131052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells
    Wang S; Li H; Ye C; Lin P; Li B; Zhang W; Sun L; Wang Z; Xue D; Teng W; Zhou X; Lin N; Ye Z
    Front Immunol; 2018; 9():377. PubMed ID: 29535738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption.
    Giusti A; Camellino D; Saverino D; Iervasi E; Girasole G; Bianchi G; Papapoulos SE
    Bone; 2020 Sep; 138():115512. PubMed ID: 32603908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
    Idrees AS; Sugie T; Inoue C; Murata-Hirai K; Okamura H; Morita CT; Minato N; Toi M; Tanaka Y
    Cancer Sci; 2013 May; 104(5):536-42. PubMed ID: 23387443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.
    Sakamoto M; Nakajima J; Murakawa T; Fukami T; Yoshida Y; Murayama T; Takamoto S; Matsushita H; Kakimi K
    J Immunother; 2011 Mar; 34(2):202-11. PubMed ID: 21304399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.
    Anastasilakis AD; Polyzos SA; Makras P; Sakellariou GT; Bisbinas I; Gkiomisi A; Delaroudis S; Gerou S; Ballaouri I; Oikonomou D; Papapoulos SE
    Bone; 2012 May; 50(5):1130-4. PubMed ID: 22366634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
    Sugai S; Yoshikawa T; Iwama T; Tsuchiya N; Ueda N; Fujinami N; Shimomura M; Zhang R; Kaneko S; Uemura Y; Nakatsura T
    Int J Oncol; 2016 May; 48(5):1794-804. PubMed ID: 26936487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Popp AW; Senn R; Curkovic I; Senn C; Buffat H; Popp PF; Lippuner K
    Osteoporos Int; 2017 Jun; 28(6):1995-2002. PubMed ID: 28299378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 conditioning of peripheral blood mononuclear cells from breast cancer patients promotes the zoledronate-induced expansion of γδ T cells in vitro and enhances their cytotoxic activity and cytokine production.
    Assy L; Khalil SM; Attia M; Salem ML
    Int Immunopharmacol; 2023 Jan; 114():109402. PubMed ID: 36481526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.